10Elms LLP
CME icon

10Elms LLP’s CME Group CME Stock Holding History

10Elms LLP’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.5K Buy
+40
New +$10.5K ﹤0.01% 456

Other funds holding CME

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

10Elms LLP's CME Position: Q3 2026 in Review

10Elms LLP opened a new position in CME Group (CME) in Q3 2026: 40 shares worth $10.5K. The stake represents ﹤0.01% of the portfolio and ranks #456 among its holdings.

1,503 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • 10Elms LLP held 40 shares of CME Group worth $10.5K as of Q3 2026.
  • CME Group was a new 10Elms LLP position in Q3 2026.
  • CME Group made up ﹤0.01% of 10Elms LLP's portfolio in Q3 2026, its #456 holding.
  • 1,503 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on 10Elms LLP's 13F filing for Q3 2026, filed 6 Nov 2026.